A phase I/II trial of combination of PKC412 and 5-azacytidine (AZA) for the treatment of patients with refractory or relapsed (R/R) acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

被引：0
|
作者：
Nazha, Aziz [1 ]
Kantarjian, Hagop [1 ]
Borthakur, Gautam [1 ]
Kadia, Tapan M. [1 ]
Faderl, Stefan [1 ]
Ravandi, Farhad [1 ]
Estrov, Zeev [1 ]
Jabbour, Elias [1 ]
Quintas-Cardama, Alfonso [1 ]
Cortes, Jorge E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6589
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Trial in Progress: An Open-Label Phase II Study of Relatlimab with Nivolumab in Combination with 5-Azacytidine for the Treatment of Patients with Relapsed/Refractory and Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia (AARON)
    Buecklein, Veit L.
    Warm, Maximilian
    Spiekermann, Karsten
    Schmidt, Christian
    Unterhalt, Michael
    Daver, Naval
    Subklewe, Marion
    BLOOD, 2022, 140 : 3227 - 3228
  • [22] A Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies.
    Ball, Edward D.
    Medeiros, Bruno C.
    Balaian, Larissa
    Roque, Tracy
    Corringham, Sue
    Rajwanshi, Richa
    Coutre, Steve
    Gotlib, Jason R.
    Bashey, Asad
    Messer, Karen
    BLOOD, 2009, 114 (22) : 809 - 809
  • [23] Update of a Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies
    Ball, Edward D.
    Medeiros, Bruno C.
    Balaian, Larissa
    Roque, Tracy
    Corringham, Sue
    Rajwanshi, Richa
    Coutre, Steven
    Gotlib, Jason R.
    Bashey, Asad
    Messer, Karen
    BLOOD, 2010, 116 (21) : 1346 - 1346
  • [24] PHASE II STUDY OF SORAFENIB AND 5-AZACYTIDINE (AZA) IN PATIENTS WITH RELAPSED, REFRACTORY OR UNTREATED AML AND FLT3-ITD MUTATION
    Ravandi, Farhad
    Alattar, Mona Lisa
    Levis, Mark
    Faderl, Stefan
    Burger, Jan
    Grunwald, Michael
    Cortes, Jorge
    Kantarjian, Hagop
    ANNALS OF HEMATOLOGY, 2013, 92 : S16 - S16
  • [25] Phase I results of decitabine in combination with midostaurin (PKC412) for elderly (age ≥ 60) newly diagnosed or relapsed/refractory adult patients with AML.
    Williams, Casey B.
    Kambhampati, Suman
    Ganguly, Siddhartha
    Aljitawi, Omar
    Wick, Jo
    Reyes, Ruben
    Fleming, Allan
    Bhalla, Kapil
    Abhyankar, Sunil
    McGuirk, Joseph
    PHARMACOTHERAPY, 2012, 32 (10): : E222 - E222
  • [26] Results of a Phase I Open-Label Study of Decitabine in Combination with Midostaurin (PKC412) for Elderly (Age ≥ 60) Newly Diagnosed or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia
    Williams, Casey B.
    Kambhampati, Suman
    Ganguly, Siddhartha
    Aljitawi, Omar S.
    Reyes, Ruben
    Fleming, Allan
    Bhalla, Kapil N.
    Abhyankar, Sunil
    McGuirk, Joseph
    BLOOD, 2011, 118 (21) : 1542 - 1542
  • [27] A PHASE I TRIAL OF LENALIDOMIDE IN COMBINATION WITH INTERMEDIATE DOSE CYTARABINE (IDC) IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) PATIENTS
    Vigil, E.
    Griffiths, A.
    Thompson, E.
    Brady, E.
    Dickey, M.
    Ford, A.
    Wang, S.
    Wetzler, M.
    HAEMATOLOGICA, 2012, 97 : 33 - 33
  • [28] A phase I/II study of topotecan, mitoxantrone and etoposide in relapsed/refractory acute myeloid leukemia (AML), myeloid blast crisis and high risk myelodysplastic syndromes (MDS).
    Nand, S
    Stiff, P
    Beltran, O
    Godwin, J
    BLOOD, 1999, 94 (10) : 234B - 234B
  • [29] Phase II study of Mylotarg plus Troxatyl in patients with refractory acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
    Giles, FJ
    Garcia-Manero, G
    O'Brien, S
    Estey, E
    Kantarjian, H
    BLOOD, 2001, 98 (11) : 212B - 212B
  • [30] a Phase I/II Study of Selinexor (SEL) with Sorafenib in Patients (pts) with Relapsed and/or Refractory (R/R) FLT3 Mutated Acute Myeloid Leukemia (AML)
    Daver, Naval
    Assi, Rita
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    Jabbour, Elias J.
    DiNardo, Courtney D.
    Kadia, Tapan
    Ning, Jing
    Gonzalez, Graciela Nogueras
    Pierce, Sherry
    Kelly, Mary
    Zhang, Weiguo
    Gombos, Dan
    Kornblau, Steven
    Konopleva, Marina
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Andreeff, Michael
    BLOOD, 2017, 130
12345